(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -27.66%-11.89M | -152.67%-52.1M | -63.19%-14.93M | -373.39%-13.72M | -144.46%-14.12M | -233.82%-9.32M | -192.69%-20.62M | -266.36%-9.15M | -69.57%-2.9M | -336.74%-5.78M |
Net income from continuing operations | -8.33%-14.96M | -121.84%-59.16M | -31.73%-15.64M | -245.58%-15.01M | -165.74%-14.7M | -180.74%-13.81M | -204.51%-26.67M | -303.97%-11.87M | -62.15%-4.34M | -245.05%-5.53M |
Operating gains losses | -437.05%-125.04K | 206.96%114.54K | -23.91%69.29K | 100.42%841 | 132.76%7.31K | 61.82%37.1K | 15.66%-107.09K | 201.46%91.06K | -169.55%-198.76K | 69.23%-22.31K |
Depreciation and amortization | 36.51%178.81K | 56.04%549.57K | 33.80%148.76K | 42.96%140K | 66.40%129.82K | 101.33%130.99K | 22.77%352.19K | 144.32%111.18K | 26.73%97.93K | 0.55%78.02K |
Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | 1,157.17%1.58M | ---- | ---- | ---- |
Remuneration paid in stock | -66.36%786.61K | 83.85%5.42M | 37.09%999.83K | 63.60%1.1M | 134.48%976.75K | 107.52%2.34M | 548.57%2.95M | 993.84%729.34K | 237.17%674.72K | 344.69%416.55K |
Other non cashItems | -18.22%17.43K | 140.98%77.81K | -22.18%17.96K | 731.84%18.58K | 550.83%19.96K | 445.76%21.31K | 37.31%32.29K | 391.15%23.08K | -59.55%2.23K | -50.91%3.07K |
Change In working capital | 12.44%2.21M | -27.57%902.34K | -380.65%-529.63K | -97.69%20K | 22.99%-554.55K | 116.17%1.97M | 31.20%1.25M | 11.95%188.72K | 14.24%867.49K | -510.15%-720.06K |
-Change in receivables | 737.66%269.52K | -46.95%-426.42K | -11.31%-302.62K | 277.63%7.75K | -223.68%-89.28K | 54.32%-42.27K | -387.60%-290.18K | -7,310.17%-271.88K | -98.06%2.05K | 463.09%72.19K |
-Change in prepaid assets | 517.48%420.68K | -587.72%-595.85K | -220.20%-207.63K | -91.40%-394.1K | 380.60%106.65K | -551.70%-100.77K | -30.75%-86.64K | 402.85%172.74K | -95.22%-205.91K | -272.92%-38.01K |
-Change in payables and accrued expense | -27.90%1.52M | 18.61%1.92M | -106.73%-19.37K | -62.07%406.35K | 24.17%-571.91K | 107.28%2.11M | 77.34%1.62M | 108.77%287.86K | 41.19%1.07M | -536.14%-754.24K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -27.66%-11.89M | -152.67%-52.1M | -63.19%-14.93M | -373.39%-13.72M | -144.46%-14.12M | -233.82%-9.32M | -192.69%-20.62M | -266.36%-9.15M | -69.57%-2.9M | -336.74%-5.78M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 37,834.06%29.03M | -3,346.31%-30.73M | -4.24%-232.41K | -4,960.76%-30.06M | -1,308.02%-359.33K | -56.33%-76.94K | -269.80%-891.75K | -177.00%-222.96K | -276.41%-594.06K | -801.45%-25.52K |
Net PPE purchase and sale | -1,159.39%-968.92K | 25.98%-732.39K | 27.52%-232.41K | 89.27%-63.71K | -1,308.02%-359.33K | -56.33%-76.94K | -310.32%-989.45K | -298.38%-320.66K | -276.41%-594.06K | -801.45%-25.52K |
Net investment purchase and sale | --30M | ---30M | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | --97.7K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 37,834.06%29.03M | -3,346.31%-30.73M | -4.24%-232.41K | -4,960.76%-30.06M | -1,308.02%-359.33K | -56.33%-76.94K | -269.80%-891.75K | -177.00%-222.96K | -276.41%-594.06K | -801.45%-25.52K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -90.45%231.96K | 59.16%81.8M | 389.99%5.63M | 94.19%70.06M | 78.14%3.68M | -79.93%2.43M | 188.67%51.39M | -85.80%1.15M | 98,331.32%36.08M | -78.88%2.07M |
Net issuance payments of debt | 2.53%-63.89K | -77.98%-262.28K | -10.79%-65.76K | -127.44%-65.47K | -125.50%-65.52K | -117.18%-65.54K | -18.34%-147.37K | -81.91%-59.35K | 5.81%-28.78K | 4.84%-29.05K |
Net common stock issuance | ---- | 44.87%70.01M | --0 | 90.78%70.01M | ---- | ---- | 361.99%48.33M | --1 | --36.7M | -98.76%130K |
Proceeds from stock option exercised by employees | -88.14%295.84K | 138.74%15.39M | 347.08%5.46M | 115.56%3.69M | 84.39%3.75M | 68.25%2.49M | -20.54%6.45M | -84.94%1.22M | --1.71M | --2.03M |
Net other financing activities | ---- | -3.26%-3.34M | 1,842.99%233.53K | ---- | ---- | ---- | -400.99%-3.23M | -253.24%-13.4K | -37,243.89%-2.3M | ---66.41K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -90.45%231.96K | 59.16%81.8M | 389.99%5.63M | 94.19%70.06M | 78.14%3.68M | -79.93%2.43M | 188.67%51.39M | -85.80%1.15M | 98,331.32%36.08M | -78.88%2.07M |
Net cash flow | ||||||||||
Beginning cash position | -3.37%42.31M | 219.06%43.51M | 0.68%52.26M | 35.23%25.95M | 60.59%36.77M | 221.11%43.79M | 343.47%13.64M | 534.08%51.91M | 91.18%19.19M | 1,397.02%22.9M |
Current changes in cash | 349.49%17.37M | -103.44%-1.03M | -15.94%-9.54M | -19.37%26.27M | -189.06%-10.8M | -175.18%-6.96M | 184.11%29.88M | -249.29%-8.23M | 1,811.11%32.58M | -144.18%-3.74M |
Effect of exchange rate changes | 301.29%109.52K | -1,243.12%-165.3K | 25.13%-133.29K | -72.56%36.84K | -145.39%-14.44K | -16,092.86%-54.41K | -128.44%-12.31K | -191.73%-178.03K | 158.13%134.25K | -39.75%31.81K |
End cash Position | 62.62%59.79M | -2.75%42.31M | -2.75%42.31M | 0.68%52.26M | 35.23%25.95M | 60.59%36.77M | 219.06%43.51M | 219.06%43.51M | 534.08%51.91M | 91.18%19.19M |
Free cash from | -36.93%-12.86M | -144.49%-52.83M | -60.12%-15.17M | -294.71%-13.79M | -149.57%-14.48M | -230.75%-9.39M | -194.55%-21.61M | -267.10%-9.47M | -83.05%-3.49M | -335.23%-5.8M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.